GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (XMAD:FAE) » Definitions » Price-to-Owner-Earnings

Faes Farma (XMAD:FAE) Price-to-Owner-Earnings : 17.89 (As of Dec. 13, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Faes Farma Price-to-Owner-Earnings?

As of today (2024-12-13), Faes Farma's share price is €3.40. Faes Farma's Owner Earnings per Share (TTM) ended in Dec. 2023 was €0.19. It's Price-to-Owner-Earnings for today is 17.89.


The historical rank and industry rank for Faes Farma's Price-to-Owner-Earnings or its related term are showing as below:

XMAD:FAE' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 0.41   Med: 14.52   Max: 26.26
Current: 18.74

During the past 13 years, the highest Price-to-Owner-Earnings of Faes Farma was 26.26. The lowest was 0.41. And the median was 14.52.


XMAD:FAE's Price-to-Owner-Earnings is ranked better than
67.13% of 432 companies
in the Drug Manufacturers industry
Industry Median: 26.71 vs XMAD:FAE: 18.74

As of today (2024-12-13), Faes Farma's share price is €3.40. Faes Farma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.19. Therefore, Faes Farma's PE Ratio (TTM) for today is 18.09.

As of today (2024-12-13), Faes Farma's share price is €3.40. Faes Farma's EPS without NRI for the trailing twelve months (TTM) ended in was €0.19. Therefore, Faes Farma's PE Ratio without NRI for today is 18.09.

During the past 13 years, Faes Farma's highest PE Ratio without NRI was 26.87. The lowest was 10.18. And the median was 18.09.


Faes Farma Price-to-Owner-Earnings Historical Data

The historical data trend for Faes Farma's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Price-to-Owner-Earnings Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.82 16.72 15.36 13.36 16.99

Faes Farma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 16.99 - -

Competitive Comparison of Faes Farma's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Faes Farma's Price-to-Owner-Earnings falls into.



Faes Farma Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Faes Farma's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.40/0.19
=17.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Faes Farma  (XMAD:FAE) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Faes Farma Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Faes Farma's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Faes Farma Business Description

Traded in Other Exchanges
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma Headlines

No Headlines